Clinical Trials at Huntsman Cancer Institute

As of June 2026, 67 paid clinical trials are recruiting at Huntsman Cancer Institute, located at 1220 E 3900 S, SUITE 4F, SALT LAKE CITY, UT 84124-1377, phone (801) 268-8223 in Salt Lake City, Utah. Compensation typically covers time, travel, and study visits — most studies also offer study-related medical care at no cost to participants.

Recruiting trial data synced daily from ClinicalTrials.gov. Last sync: June 12, 2026.

Filter results

Filter results

State

City

Facility

Phase

Study type

Intervention

Recruitment status

Condition

Sex

Age

Healthy volunteers only

67 clinical trials at Huntsman Cancer Institute

·Clear filters·↓ Download CSV

Zanubrutinib and Lisocabtagene Maraleucel for the Treatment of Richter's Syndrome

for Recurrent Transformed Chronic Lymphocytic Leukemia

3 locations incl. New York

Sponsor: Aseel Alsouqi

Sex: All·Age: 18+

Code: NCT05873712·Phase 2·Recruiting

Apply to this trial

Pembro With Radiation With or Without Olaparib

for Prostate Cancer

2 locations incl. Lexington

Sponsor: Zin W Myint

Sex: Male·Age: 18+

Code: NCT05568550·Phase 2·Recruiting

Apply to this trial

A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma

for Glioblastoma IDH (Isocitrate Dehydrogenase) Wildtype

8 locations incl. Chicago

Sponsor: Debiopharm International SA

Sex: All·Age: 18+

Code: NCT05765812·Phase 1, Phase 2·Recruiting

Apply to this trial

Study of Rondecabtagene Autoleucel in Aggressive Large B-Cell Lymphoma

for Relapsed Non-Hodgkin Lymphoma

32 locations incl. Irvine

Sponsor: Lyell Immunopharma, Inc.

Sex: All·Age: 18+

Code: NCT05826535·Phase 1, Phase 2·Recruiting

Apply to this trial

Undergraduate Skin Cancer Prevention Trial

for Skin Cancer

1 location in Salt Lake City

Sponsor: University of Utah

Sex: All·Age: 18+·Accepts healthy volunteers

Code: NCT05634252·Phase 3·Recruiting

Apply to this trial

Tafasitamab and Rituximab for Front-Line Treatment of Post-Transplant Lymphoproliferative Disorder

for Monomorphic B-Cell Post-Transplant Lymphoproliferative Disorder

Drug: Tafasitamab

4 locations incl. New Brunswick

Sponsor: Timothy Voorhees

Sex: All·Age: 18+

Code: NCT05786040·Phase 2·Recruiting

Apply to this trial

Post-Autologous Transplant Maintenance With Isatuximab and Lenalidomide in Minimal Residual Disease Positive Multiple Myeloma

for Multiple Myeloma

2 locations incl. Chicago

Sponsor: University of Illinois at Chicago

Sex: All·Age: 18+

Code: NCT05344833·Phase 2·Recruiting

Apply to this trial

Study of Sacituzumab Govitecan-hziy and Pembrolizumab Versus Treatment of Physician's Choice in Patients With Triple Negative Breast Cancer Who Have Residual Invasive Disease After Surgery and Neoadjuvant Therapy (ASCENT-05/AFT-65 OptimICE-RD/GBG 119/NSABP B-63)

for Triple Negative Breast Cancer

184 locations incl. Birmingham

Sponsor: Gilead Sciences

Sex: All·Age: 18+

Code: NCT05633654·Phase 3·Recruiting

Apply to this trial

A Study of Teclistamab in Combination With Daratumumab and Lenalidomide (Tec-DR) and Talquetamab in Combination With Daratumumab and Lenalidomide (Tal-DR) in Participants With Newly Diagnosed Multiple Myeloma

for Multiple Myeloma

Drug: Daratumumab

67 locations incl. Gilbert

Sponsor: Janssen Research & Development, LLC

Sex: All·Age: 18+

Code: NCT05552222·Phase 3·Recruiting

Apply to this trial

A Study of XMT-1660 in Participants With Solid Tumors

for Triple Negative Breast Cancer

26 locations incl. Phoenix

Sponsor: Mersana Therapeutics

Sex: All·Age: 18+

Code: NCT05377996·Phase 1·Recruiting

Apply to this trial

A Study to Evaluate the Safety and Anti-cancer Activity of Loncastuximab Tesirine in Combination With Other Anti-cancer Agents in Participants With Relapsed or Refractory B-cell Non-Hodgkin Lymphoma (LOTIS-7)

for B-Cell Non-Hodgkin Lymphoma

25 locations incl. Clovis

Sponsor: ADC Therapeutics S.A.

Sex: All·Age: 18+

Code: NCT04970901·Phase 1·Recruiting

Apply to this trial

Study of RMC-6236 in Patients With Advanced Solid Tumors Harboring Specific Mutations in RAS

for Non-small Cell Lung Cancer (NSCLC)

21 locations incl. Orange

Sponsor: Revolution Medicines, Inc.

Sex: All·Age: 18+

Code: NCT05379985·Phase 1, Phase 2·Recruiting

Apply to this trial

Open-label Study of ELA026 in Participants With Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

for Secondary Hemophagocytic Lymphohistiocytosis (sHLH)

18 locations incl. Birmingham

Sponsor: Electra Therapeutics Inc.

Sex: All·Age: 6+

Code: NCT05416307·Phase 2, Phase 3·Recruiting

Apply to this trial

Asciminib as Initial Therapy for Patients With Chronic Myeloid Leukemia in Chronic Phase

for Chronic Myeloid Leukemia, Chronic Phase

7 locations incl. Atlanta

Sponsor: University of Alabama at Birmingham

Sex: All·Age: 18+

Code: NCT05143840·Phase 2·Recruiting

Apply to this trial

A Study of NX-5948 in Adults With Relapsed/Refractory B-cell Malignancies

for Chronic Lymphocytic Leukemia (CLL)

18 locations incl. Duarte

Sponsor: Nurix Therapeutics, Inc.

Sex: All·Age: 18+

Code: NCT05131022·Phase 1·Recruiting

Apply to this trial

A Phase 1/2 Study of Enzomenib (DSP-5336) in Patients With Acute Leukemia (Horizen-1)

for Leukemia, Myeloid, Acute

33 locations incl. Newport Beach

Sponsor: Sumitomo Pharma America, Inc.

Sex: All·Age: 12+

Code: NCT04988555·Phase 1, Phase 2·Recruiting

Apply to this trial

Protocol Number: HJKC3-0003. Treatment Free Remission After Asciminib Based Therapy in Chronic Phase Chronic Myeloid Leukemia (CP-CML) Patients Who Relapsed After a Prior Attempt at TKI Discontinuation

for Chronic Phase Chronic Myelogenous Leukemia

4 locations incl. Detroit

Sponsor: Medical College of Wisconsin

Sex: All·Age: 18+

Code: NCT04838041·Phase 2·Recruiting

Apply to this trial

Hypoxia Imaging for Esophageal Cancer to Guide Personalized Radiation Therapy

for Esophageal Cancer

1 location in Salt Lake City

Sponsor: University of Utah

Sex: All·Age: 18+

Code: NCT04846309·Phase 1·Recruiting

Apply to this trial

A Phase 1b/2 Study of Sonrotoclax (BGB-11417) as Monotherapy and in Various Combinations With Dexamethasone Plus Carfilzomib, Dexamethasone Plus Daratumumab, and Dexamethasone Plus Pomalidomide in Multiple Myeloma

for Relapsed/Refractory Multiple Myeloma

Drug: Daratumumab

16 locations incl. Birmingham

Sponsor: BeOne Medicines

Sex: All·Age: 18+

Code: NCT04973605·Phase 1, Phase 2·Recruiting

Apply to this trial

Ribociclib&Belinostat In Patients w Metastatic Triple Neg Breast Cancer & Recurrent Ovarian Cancer w Response Prediction By Genomics

for Metastatic Breast Cancer

Drug: Ribociclib

2 locations incl. Salt Lake City

Sponsor: University of Utah

Sex: All·Age: 18+

Code: NCT04315233·Phase 1·Recruiting

Apply to this trial

Study of Pelvic Hypofractionated Radiotherapy in Endometrial Cancer

for Endometrial Cancer

5 locations incl. Atlanta

Sponsor: University of Chicago

Sex: Female·Age: 18+

Code: NCT04683653·Phase 1, Phase 2·Recruiting

Apply to this trial

Pancreatic Cancer Early Detection Consortium

for Pancreas Cancer

45 locations incl. Phoenix

Sponsor: Arbor Research Collaborative for Health

Sex: All·Age: 18 - 90·Accepts healthy volunteers

Code: NCT04970056·Recruiting

Apply to this trial

A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis

for Myelofibrosis

32 locations incl. Birmingham

Sponsor: Sumitomo Pharma America, Inc.

Sex: All·Age: 18+

Code: NCT04176198·Phase 1, Phase 2·Recruiting

Apply to this trial

Study Evaluating Safety and Efficacy of JCAR017 in Subjects With Relapsed or Refractory Chronic Lymphocytic Leukemia (CLL) or Small Lymphocytic Lymphoma (SLL)

for Leukemia, Lymphocytic, Chronic, B-Cell

84 locations incl. Birmingham

Sponsor: Juno Therapeutics, a Subsidiary of Celgene

Sex: All·Age: 18+

Code: NCT03331198·Phase 1, Phase 2·Recruiting

Apply to this trial

INdividualized Screening Trial of Innovative Glioblastoma Therapy (INSIGhT)

for Glioblastoma

12 locations incl. Birmingham

Sponsor: Patrick Wen, MD

Sex: All·Age: 18+

Code: NCT02977780·Phase 2·Recruiting

Apply to this trial

Stereotactic Radiosurgery Dose Escalation for Brain Metastases

for Brain Metastases

1 location in Salt Lake City

Sponsor: University of Utah

Sex: All·Age: 18+

Code: NCT02390518·Phase 1·Recruiting

Apply to this trial

ColoCare Study - Colorectal Cancer Cohort

for Colorectal Cancer

6 locations incl. Los Angeles

Sponsor: University of Utah

Sex: All·Age: 18 - 89

Code: NCT02328677·Recruiting

Apply to this trial